Physician profile

Thomas Suits

Stuart, FL

NPI 1629047030

$7,258.90

in general payments reported to CMS, 2019-2025

40 companies · $547 in 2025

The $547 reported for 2025 was more than what 80% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,553.45
Education$298.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Endo Pharmaceuticals INC. $1,710.25 2019-2024 Aveed
Janssen Biotech, INC. $875.03 2019-2025 Erleada
Abbvie INC. $651.63 2019-2025 Lupron Depot
Boston Scientific Corporation $628.20 2019-2025 Spaceoar Vue System - 10ml, Lithovue, Axonics
Astellas Pharma US INC $589.48 2019-2025 Xtandi, Myrbetriq
Coloplast Corp $513.13 2019-2025 Speedicath
Endo USA, INC. $405.91 2024-2025 Aveed
Teleflex LLC $152.80 2024-2025 Urolift, Barrigel
Axonics, INC. $115.10 2022-2024 Axonics, Bulkamid
Rochester Medical Corporation $114.57 2019-2022
Bayer Healthcare Pharmaceuticals INC. $114.44 2020-2022
Myriad Genetic Laboratories, INC. $108.09 2021-2024 Prolaris
Convatec INC. $104.44 2020-2022
Medtronic, INC. $102.39 2021-2024 Interstim
Olympus America INC. $93.92 2022-2025 Gyrus Acmi, Itind System
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Urogen Pharma, INC. $93.84 2021-2023 Jelmyto
Procept Biorobotics Corporation $86.22 2022-2024 Aquabeam System
Blue Earth Diagnostics $80.93 2019-2024
Merck Sharp & Dohme LLC $70.43 2020-2024 Bridion
C. R. Bard, INC. & Subsidiaries $62.52 2019
Kowa Pharmaceuticals America, INC. $62.28 2023 Seglentis
Antares Pharma, INC. $62.24 2025 Xyosted
Allergan, INC. $54.94 2019-2022
Tolmar, INC. $50.08 2024-2025 Eligard, Jatenzo
Laborie Medical Technologies Corp. $35.37 2021
Novartis Pharmaceuticals Corporation $33.99 2022
Accord Healthcare, INC. $32.43 2022
Myovant Sciences INC. $29.66 2021
180 Medical, INC. $28.99 2024
Telix Pharmaceuticals $23.31 2023 Illuccix
Astrazeneca Pharmaceuticals LP $21.77 2022
Seagen INC. $20.57 2019
Philips North America LLC $19.53 2025 Oncology Solution
Ambu INC. $19.47 2025
Pfizer INC. $17.85 2019
Immunitybio, INC. $17.79 2024
Sun Pharmaceutical Industries INC. $17.39 2021
Urovant Sciences INC $17.09 2022
Dentsply Ih INC. $15.08 2021
Clarus Therapeutics INC. $5.75 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Suits

$7,258.90

in general payments reported 2019-2025

Years
2019-2025
Top company
Endo Pharmaceuticals INC.
Context
The $547 reported for 2025 was more than what 80% of providers received nationally.

https://glasscript.com/doctor/1296478/thomas-suits

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.